« FDA Approvals: ‘We Are Back On Track’ | Main | BMS and AZ Team up to Buy Amylin at Premium »

06/30/2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b017742dd7c12970d

Listed below are links to weblogs that reference Biogen Idec and Isis Deal: Antisense Resurgence?:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

BioDueDiligence

Completely agree, these monogenic diseases are perfect for antisense/RNAi attempts. If only ISIS had gone in this direction sooner I think patients and shareholders would have been better off

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada